News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) To Collaborate With Shanghai Institutes for Biological Sciences On Cardiovascular Disease


1/29/2014 9:03:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 28, 2014 -- AstraZeneca and the Shanghai Institutes of Biological Sciences (SIBS) agreed to collaborate on a basic research project in cardiovascular disease. The two entities will seek to understand the development process for coronary vessels. The collaboration will focus on vessels that supply blood to the heart and will also attempt to regenerate the main branch to the heart. The ultimate goal of the project is to develop innovative treatments for cardiovascular disease. More details....

Stock Symbol: (NYSE: AZN)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES